Effects of systemic treatment with irbesartan and losartan on central responses to angiotensin II in conscious, normotensive rats.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  European Journal of Pharmacology

• Publication date

  1999-02-19

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/S0014-2999(98)00983-2PMID 10079000
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Evaluation of the ability of irbesartan to cross the blood-brain barrier following acute intragastric treatment.

  1998cited by this paper
• Irbesartan. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in the management of hypertension.

  1997cited by this paper
• A new formalin test allowing simultaneous evaluation of cardiovascular and nociceptive responses.

  1997cited by this paper
• Distribution of angiotensin type-1 receptor messenger RNA expression in the adult rat brain.

  1997cited by this paper
• Pharmacokinetic-Pharmacodynamic Profile of Angiotensin II Receptor Antagonists

  1997cited by this paper
• Angiotensin receptors and their therapeutic implications.

  1996cited by this paper
• Functional evidence for the ability of angiotensin AT1 receptor antagonists to cross the blood-brain barrier in rats.

  1996cited by this paper
• Angiotensin receptors.

  1996cited by this paper
• Proceedings of the Symposium ‘Angiotensin AT1 Receptors: From Molecular Physiology to Therapeutics’: ROLE OF AT1 RECEPTORS IN THE CENTRAL CONTROL OF SYMPATHETIC VASOMOTOR FUNCTION

  1996cited by this paper
• Angiotensin receptors in the brain.

  1995cited by this paper
• The selective angiotensin AT1 receptor antagonist LR-B/081 potently inhibits drinking induced by central injection of angiotensin II in rats.

  1995cited by this paper
• Hemodynamic and biochemical effects of the AT1 receptor antagonist irbesartan in hypertension.

  1995cited by this paper
• Lack of a centrally‐mediated antihypertensive effect following acute or chronic central treatment with AT1‐receptor antagonists in spontaneously hypertensive rats

  1995cited by this paper
• Repeated measurements and multiple comparisons in cardiovascular research.

  1994cited by this paper
• BLOCKADE BY INTRAVENOUS LOSARTAN OF AT1 ANGIOTENSIN II RECEPTORS IN RAT BRAIN, KIDNEY AND ADRENALS DEMONSTRATED BY IN VITRO AUTORADIOGRAPHY

  1994cited by this paper
• Angiotensin II receptors in SFO but not in OVLT mediate isoproterenol-induced thirst.

  1994cited by this paper
• Functional evidence that the angiotensin antagonist losartan crosses the blood-brain barrier in the rat.

  1993cited by this paper
• Pharmacological characterization of SR 47436, a new nonpeptide AT1 subtype angiotensin II receptor antagonist.

  1993cited by this paper
• Angiotensin II receptors and angiotensin II receptor antagonists.

  1993cited by this paper
• Antisense inhibition of AT1 receptor mRNA and angiotensinogen mRNA in the brain of spontaneously hypertensive rats reduces hypertension of neurogenic origin.

  1993cited by this paper
• Angiotensin II-induced vasopressin release is mediated through alpha-1 adrenoceptors and angiotensin II AT1 receptors in the supraoptic nucleus.

  1993cited by this paper
• Central DuP 753 Does Not Lower Blood Pressure in Spontaneously Hypertensive Rats

  1992cited by this paper
• Involvement of adrenergic and angiotensinergic receptors in the paraventricular nucleus in the angiotensin II-induced vasopressin release.

  1992cited by this paper
• Role of brain angiotensin in cardiovascular regulation.

  1992cited by this paper
• Mapping of angiotensin II receptor subtype heterogeneity in rat brain

  1992cited by this paper
• Losartan potassium, a nonpeptide antagonist of angiotensin II, chronically administered p.o. does not readily cross the blood-brain barrier.

  1992cited by this paper
• Brain and pituitary angiotensin.

  1992cited by this paper
• The role of angiotensin, AT1 and AT2 receptors in the pressor, drinking and vasopressin responses to central angiotensin.

  1992cited by this paper
• Distribution of angiotensin II receptor subtypes in rat brain nuclei.

  1991cited by this paper
• ON MAKING MULTIPLE COMPARISONS IN CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY

  1991cited by this paper
• Effects of chemical stimulation of the subfornical organ on metabolic activity of the hypothalamo-neurohypophysial system in rats.

  1991cited by this paper
• Access of peripherally administered DuP 753 to rat brain angiotensin II receptors

  1991cited by this paper
• Projections from the subfornical organ to the supraoptic nucleus in the rat: ultrastructural identification of an interposed synapse in the median preoptic nucleus using a combination of neuronal tracers.

  1991cited by this paper
• Nonpeptide angiotensin II receptor antagonists. IX. Antihypertensive activity in rats of DuP 753, an orally active antihypertensive agent.

  1990cited by this paper
• The Neuroendocrinology of Thirst: Afferent Signaling and Mechanisms of Central Integration

  1990cited by this paper
• CIRCUMVENTRICULAR ORGANS - NEUROENDOCRINE INTERFACES BETWEEN THE BRAIN AND THE HEMAL MILIEU

  1990cited by this paper
• Nonpeptide angiotensin II receptor antagonists. VIII. Characterization of functional antagonism displayed by DuP 753, an orally active antihypertensive agent.

  1990cited by this paper
• Nonpeptide angiotensin II receptor antagonists. XI. Pharmacology of EXP3174: an active metabolite of DuP 753, an orally active antihypertensive agent.

  1990cited by this paper
• Brain angiotensin in the developing spontaneously hypertensive rat.

  1988cited by this paper
• Increased concentration of angiotensin II binding sites in selected brain areas of spontaneously hypertensive rats.

  1988cited by this paper
• Brain angiotensin: pathways and pharmacology

  1988cited by this paper
• Impaired drinking responses of rats with lesions of nucleus medianus: circadian dependence.

  1985cited by this paper
• Organization of angiotensin II immunoreactive cells and fibers in the rat central nervous system. An immunohistochemical study.

  1985cited by this paper
• Increased angiotensin II binding affinity in the nucleus tractus solitarius of spontaneously hypertensive rats.

  1985cited by this paper
• Differential Effects of Central Angiotensin II and Substance P on Sympathetic Nerve Activity in Conscious Rats Implications for Cardiovascular Adaptation to Behavioral Responses

  1985cited by this paper
• Deficits in drinking and vasopressin secretion after lesions of the nucleus medianus.

  1983cited by this paper
• Vasopressin in the plasma of stroke-prone spontaneously hypertensive rats.

  1981cited by this paper

• Tunable Biased Signaling of the Angiotensin II Type 1 Receptor for Inotropy via C-Terminal Peptide Engineering and Allosteric Site Targeting.

  2026cites this paper
• Tunable Bias Signaling of the Angiotensin II Type 1 Receptor for Inotropy via C-Terminal Peptide Modifications and Allosteric Site Targeting

  2025cites this paper
• Effect of heat stress on the hypothalamic expression profile of water homeostasis‐associated genes in low‐ and high‐water efficient chicken lines

  2024cites this paper
• Aerobic Physical Exercise is Essential for Cardiac Autonomic Regulation in Hypertensive Patients Undergoing Chronic Treatment with Renin-Angiotensin System Inhibitors.

  2023cites this paper
• Angiotensin II regulates the neural expression of subjective fear in humans - precision pharmaco-neuroimaging approach

  2022cites this paper
• Physical exercise is essential for cardiac autonomic regulation in hypertensive patients treated with losartan or enalapril

  2022cites this paper
• Combined effects of angiotensin receptor blocker use and physical training in hypertensive men

  2022cites this paper
• Angiotensin antagonist inhibits preferential negative memory encoding via decreasing hippocampus activation and its coupling with amygdala

  2021cites this paper
• The angiotensin antagonist Losartan shifts social reward motivation and punishment sensitivity via modulating midbrain-striato-frontal circuits

  2021cites this paper
• A Potential Interface between the Kynurenine Pathway and Autonomic Imbalance in Schizophrenia

  2021cites this paper
• The Angiotensin Antagonist Losartan Modulates Social Reward Motivation and Punishment Sensitivity via Modulating Midbrain-Striato-Frontal Circuits

  2021cites this paper
• Telmisartan prevents high-fat diet-induced neurovascular impairments and reduces anxiety-like behavior

  2021cites this paper
• Safety and efficacy of losartan for the reduction of brain atrophy in clinically diagnosed Alzheimer's disease (the RADAR trial): a double-blind, randomised, placebo-controlled, phase 2 trial

  2021cites this paper
• Losartan to slow the progression of mild-to-moderate Alzheimer’s disease through angiotensin targeting: the RADAR RCT

  2021cites this paper
• Brain angiotensin II and angiotensin IV receptors as potential Alzheimer’s disease therapeutic targets

  2020cites this paper
• Losartan attenuates neuroinflammation and neuropathic pain in paclitaxel‐induced peripheral neuropathy

  2020cites this paper
• Losartan treatment attenuates the development of neuropathic thermal hyperalgesia induced by peripheral nerve injury in rats

  2019cites this paper
• The AT1 Receptor Antagonist Losartan Does Not Affect Depressive-Like State and Memory Impairment Evoked by Chronic Stressors in Rats

  2019cites this paper
• The subfornical organ drives hypertension in polycystic kidney disease via the hypothalamic paraventricular nucleus.

  2019cites this paper
• Human extinction learning is accelerated by an angiotensin antagonist via ventromedial prefrontal cortex and its connections with basolateral amygdala

  2019cites this paper
• Angiotensin II Type 1 Receptor Blockers Inhibit KAT II Activity in the Brain—Its Possible Clinical Applications

  2017cites this paper
• Neuroprotective effects of AT1 receptor antagonists after experimental ischemic stroke: what is important?

  2017cites this paper
• The Rationale and Design of the Reducing Pathology in Alzheimer’s Disease through Angiotensin TaRgeting (RADAR) Trial

  2017cites this paper
• Physical training associated with Enalapril but not to Losartan, results in better cardiovascular autonomic effects.

  2017cites this paper
• Estudo da associação do treinamento físico aeróbio com diferentes terapias farmacológicas sobre as adaptações autonômicas cardíacas em ratos espontaneamente hipertensos (SHR)

  2016cites this paper
• Angiotensin II type 1 receptor antagonists in animal models of vascular, cardiac, metabolic and renal disease.

  2016influential citation
• Involvement of Type 1 Angiontensin II Receptor (AT1) in Cardiovascular Changes Induced by Chronic Emotional Stress: Comparison between Homotypic and Heterotypic Stressors

  2016cites this paper
• Effects of AT1 receptor antagonism on kainate-induced seizures and concomitant changes in hippocampal extracellular noradrenaline, serotonin, and dopamine levels in Wistar-Kyoto and spontaneously hypertensive rats.

  2015cites this paper
• Opposing tissue-specific roles of angiotensin in the pathogenesis of obesity, and implications for obesity-related hypertension.

  2015cites this paper
• Effect of Combined Treatment with AT1 Receptor Antagonists and Tiagabine on Seizures, Memory and Motor Coordination in Mice.

  2015cites this paper
• Angiotensin II receptor blockade promotes repair of skeletal muscle through down-regulation of aging-promoting C1q expression

  2015cites this paper
• Tissue-specific roles for the renin-angiotensin system in cardiovascular and metabolic regulation

  2015cites this paper
• Circulating Angiotensin II Gains Access to the Hypothalamus and Brain Stem During Hypertension via Breakdown of the Blood–Brain Barrier

  2014cites this paper
• Influence of losartan intake on the circadian rhythm of melatonin secretion in humans.

  2014cites this paper
• Interactions between angiotensin AT1 receptor antagonists and second‐generation antiepileptic drugs in the test of maximal electroshock

  2014cites this paper
• A Systematic Comparison of the Properties of Clinically Used Angiotensin II Type 1 Receptor Antagonists

  2013influential citation
• Endogenous angiotensin II and the regulation of oxygen consumption and colonic temperature in rats

  2012cites this paper
• Interaction between Dopaminergic and Angiotensinergic Systems on Thirst in Adult Male Rats

  2012cites this paper
• Brain angiotensin AT1 receptors as specific regulators of cardiovascular reactivity to acute psychoemotional stress

  2011cites this paper
• The central mechanism underlying hypertension: a review of the roles of sodium ions, epithelial sodium channels, the renin–angiotensin–aldosterone system, oxidative stress and endogenous digitalis in the brain

  2011cites this paper
• The Renin-Angiotensin Axis Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers

  2011cites this paper
• Weight loss and hypophagia after high-dose AT1-blockade is only observed after high dosing and depends on regular leptin signalling but not blood pressure

  2011cites this paper
• Central Pressor Response by Olmesartan in the Rostral Ventrolateral Medulla of Spontaneously Hypertensive Rats

  2010cites this paper
• Angiotensin AT1 receptor antagonists enhance the anticonvulsant action of valproate in the mouse model of maximal electroshock.

  2010cites this paper
• Neuroendocrine characterization and anorexigenic effects of telmisartan in diet- and glitazone-induced weight gain.

  2010cites this paper
• Response of cardiac sympathetic nerve activity to intravenous irbesartan in heart failure.

  2010cites this paper
• Prevention of stroke: new evidence

  2009cites this paper
• Activity in the Brain Impairs Baroreflex Function in Hypertensive Mice Angiotensin II Type 1 Receptor-Mediated Reduction of Angiotensin-Converting Enzyme 2

  2009cites this paper
• Anti-hypertensive effects of central ablations in spontaneously hypertensive rats

  2009cites this paper
• Antihypertensive effects of central ablations in spontaneously hypertensive rats.

  2009cites this paper
• Is neurogenic hypertension related to vascular inflammation of the brainstem?

  2009cites this paper
• Preventing stroke in hypertensive patients at risk.

  2008cites this paper
• Administration of angiotensin II in the paraventricular nucleus protects gastric mucosa from ischemia-reperfusion injury.

  2008cites this paper
• Enhanced water and salt intake in transgenic mice with brain-restricted overexpression of angiotensin (AT1) receptors.

  2008cites this paper
• Increased sympathetic activity in rats submitted to chronic intermittent hypoxia

  2007cites this paper
• Comparison between early and delayed systemic treatment with candesartan of rats after ischaemic stroke

  2007cites this paper
• Telmisartan ramipril combination therapy reduces strokes and improves cardiac and renal protection in stroke prone spontaneously hypertensive rats.

  2007cites this paper
• Prevention of stroke in patients with hypertension.

  2007cites this paper
• Hypophagic effect of the angiotensin AT1 receptor antagonist irbesartan in rats.

  2007cites this paper
• Angiotensin receptor blockers and cerebral protection in stroke

  2006cites this paper
• Managing the patient at risk for a second stroke

  2005cites this paper
• Clinical Pharmacokinetics of Losartan

  2005cites this paper
• Effects of losartan and irbesartan administration on brain angiotensinogen mRNA levels.

  2005cites this paper
• Are angiotensin receptor blockers neuroprotective?

  2004cites this paper
• Role of angiotensin II and the subfornical organ in the pharmacological actions of ethanol.

  2004cites this paper
• AT1 Receptor blockade limits myocardial injury and upregulates AT2 receptors during reperfused myocardial infarction

  2004cites this paper
• AT1receptor blockade alters metabolic, functional and structural proteins after reperfused myocardial infarction: Detection using proteomics

  2004cites this paper
• Central AII evokes a normal sodium appetite in the Fischer rat, but its low spontaneous sodium intake may be related to reduced excitation and increased inhibition in septo-preoptic AII neurons.

  2004cites this paper
• Angiotensin, Neuroplasticity and Stroke

  2004cites this paper
• Upregulation of Angiotensin II Type 2 Receptor and Limitation of Myocardial Stunning by Angiotensin II Type 1 Receptor Blockers during Reperfused Myocardial Infarction in the Rat

  2003cites this paper
• Comparison of the Effects of Captopril and Valsartan on Heart Rate Variability in Healthy Men

  2003cites this paper
• Central Nervous System Blockade by Peripheral Administration of AT1 Receptor Blockers

  2003cites this paper
• Angiotensin AT1/AT2 Receptors: Regulation, Signalling and Function

  2003cites this paper
• In vivo gene transfer to dissect neuronal mechanisms regulating cardiorespiratory function.

  2003cites this paper
• Inhibiting angiotensin receptors in the brain: possible therapeutic implications

  2003cites this paper
• Effects of orally applied candesartan cilexetil on central responses to angiotensin II in conscious rats

  2002cites this paper
• The renin-angiotensin system in the brain: possible therapeutic implications for AT1-receptor blockers

  2002cites this paper
• Peripherally applied candesartan inhibits central responses to angiotensin II in conscious rats

  2002cites this paper
• AT(1) receptor blockade with losartan during gestation in Wistar rats leads to an increase in thirst and sodium appetite in their adult female offspring.

  2002cites this paper
• Angiotensin II-induced drinking and pressor responses to central or systemic irbesartan and losartan.

  2002cites this paper
• Inhibiting Renin-Angiotensin in the Brain: the Possible Therapeutic Implications

  2001cites this paper
• The influence of chronic antihypertensive treatment on the central pressor response in SHR.

  2001cites this paper
• Effects of angiotensin II (AT1) receptor blockade on cardiac vagal control in heart failure.

  2001cites this paper
• Impact of the renin‐angiotensin system on cerebral perfusion following subarachnoid haemorrhage in the rat

  2001cites this paper
• AT1 receptor antagonist telmisartan administered peripherally inhibits central responses to angiotensin II in conscious rats.

  2001cites this paper
• Peripheral administration of AT1 receptor blockers and pressor responses to central angiotensin II and sodium.

  2001cites this paper
• Pharmacotherapy in congestive heart failure: angiotensin II and thirst: therapeutic considerations.

  2001cites this paper
• Experimental Heart Failure Beneficial Effects on Skeletal Muscle of the Angiotensin II Type 1 Receptor Blocker Irbesartan in

  2001cites this paper
• The renin-angiotensin system in the brain : an update

  2001cites this paper
• The angiotensin II AT1 receptor antagonist irbesartan prevents thromboxane A2-induced vasoconstriction in the rat hind-limb vascular bed in vivo

  2001cites this paper
• AT(1) receptor blockers prevent sympathetic hyperactivity and hypertension by chronic ouabain and hypertonic saline.

  2001cites this paper
• Enhanced central response to dehydration in mice lacking angiotensin AT(1a) receptors.

  2001cites this paper
• Review: The renin-angiotensin system in the brain: an update

  2001cites this paper
• Angiotensin II and Thirst: Therapeutic Considerations

  2001cites this paper
• Prevention of Hypertension by Irbesartan in Dahl S Rats Relates to Central Angiotensin II Type 1 Receptor Blockade

  2001cites this paper
• Arterial reactivity and cardiac natriuretic peptides in genetic hypertension, nitric oxide deficiency and renal failure

  2000cites this paper
• Irbesartan: an updated review of its use in cardiovascular disorders.

  2000cites this paper
• Chronic peripheral administration of the angiotensin II AT(1) receptor antagonist candesartan blocks brain AT(1) receptors.

  2000cites this paper
• Irbesartan

  2000cites this paper
• Estradiol Attenuates Angiotensin-Induced Aldosterone Secretion in Ovariectomized Rats* *This work was supported by NIH Grants HL-57502 (to K.S.), AG-16902 (to K.S.), and DK-38094 (to J.G.V.).

  2000cites this paper